Description

Parenteral nutrition is the feeding of nutritional products to a person intravenously, bypassing the usual process of eating and digestion. The products provide liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals and electrolytes. Some people use parenteral nutrition to supplement feeding through a tube placed into the stomach or small bowel (enteral nutrition), and others use it by itself. The global parenteral nutrition market is poised to grow by US$ 1,564.4 million from 2022 to 2028, registering a CAGR of 4.1% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for parenteral nutrition. The global parenteral nutrition market is segmented on the basis of type, consumer, end user, and region. By type, the global parenteral nutrition market has been segmented into carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, vitamins & minerals. Based upon consumer, the global parenteral nutrition market is categorized into adults, children and newbowns. On the basis of end user, the global parenteral nutrition market has been segmented into hospitals & clinics, long term conditions care, home care. In terms of geography, the global parenteral nutrition market has been segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global parenteral nutrition market is highly competitive. Some of the leading companies operating in the market are Allergan plc, B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Otsuka Pharmaceutical Factory Inc., Sichuan Kelun Pharmaceutical Co. Ltd., ICU Medical Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the parenteral nutrition market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Type: carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, vitamins & minerals
Consumer: adults, children and newbowns
End user: hospitals & clinics, long term conditions care, home care
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global parenteral nutrition market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Parenteral nutrition market overview
Part 3. Market breakdown by type
– Carbohydrates
– Parenteral lipid emulsion
– Single dose amino acid solution
– Trace elements
– Vitamins & minerals
Part 4. Market breakdown by consumer
– Adults
– Children and newbowns
Part 5. Market breakdown by end user
– Hospitals & clinics
– Long term conditions care
– Home care
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Allergan plc
– B. Braun Melsungen AG
– Baxter International Inc.
– Fresenius Kabi AG
– Grifols, S.A.
– Otsuka Pharmaceutical Factory, Inc.
– Sichuan Kelun Pharmaceutical Co., Ltd.
– ICU Medical, Inc.
About StrategyHelix
Disclaimer